Performance of Circulating Tumor DNA (ctDNA) Genomic and Epigenomic Profiling (GuardantINFINITY) in the TRESR and ATTACC Studies

• I. Silverman,
• J. Schonhoft,
• A. Yablonovitch,
• E. Lagow,
• M. Cecchini,
• B. Herzberg,
• J. Reis-Filho,
• E. Rosen,
• V. Rimkunas,
• T. Yap

Affiliations

I. Silverman

Repare Therapeutics, Cambridge, USA

J. Schonhoft

Repare Therapeutics, Cambridge, USA

A. Yablonovitch

Guardant Health, Palo Alto, USA

E. Lagow

Guardant Health, Palo Alto, USA

M. Cecchini

Yale School of Medicine, New Haven, USA

B. Herzberg

Columbia University Cancer Center, New York, USA

J. Reis-Filho

Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, USA

E. Rosen

Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, USA

V. Rimkunas

Repare Therapeutics, Cambridge, USA

T. Yap

Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA